Transcept Pharmaceuticals (TSPT +7.3%) pops after saying it received notice from the FDA...

|By:, SA News Editor

Transcept Pharmaceuticals (TSPT +7.3%) pops after saying it received notice from the FDA generally agreeing with the company's proposals to address concerns over the July rejection of its insomnia treatment Intermezzo.